These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7516085

  • 21. Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.
    Alfredsson G, Wiesel FA.
    Psychopharmacology (Berl); 1989; 99(3):322-7. PubMed ID: 2480613
    [Abstract] [Full Text] [Related]

  • 22. Clonidine in the treatment of mixed bipolar disorder.
    Kontaxakis V, Markianos M, Markidis M, Stefanis C.
    Acta Psychiatr Scand; 1989 Jan; 79(1):108-10. PubMed ID: 2467523
    [Abstract] [Full Text] [Related]

  • 23. Plasma monoamine metabolites and aggression: two studies of normal and oppositional defiant disorder children.
    van Goozen SH, Matthys W, Cohen-Kettenis PT, Westenberg H, van Engeland H.
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):141-7. PubMed ID: 10082240
    [Abstract] [Full Text] [Related]

  • 24. Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics.
    Csernansky JG, Newcomer JW, Jackson K, Lombrozo L, Faull KF, Zipursky R, Pfefferbaum A, Faustman WO.
    Psychopharmacology (Berl); 1994 Nov; 116(3):291-6. PubMed ID: 7534423
    [Abstract] [Full Text] [Related]

  • 25. Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.
    Alfredsson G, Wiesel FA.
    Psychopharmacology (Berl); 1990 Nov; 101(3):324-31. PubMed ID: 2362952
    [Abstract] [Full Text] [Related]

  • 26. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [Abstract] [Full Text] [Related]

  • 27. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF, Waldmeier P, Beckmann H.
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [Abstract] [Full Text] [Related]

  • 28. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A, Ninan P, Mazonson A, Pickar D, Van Kammen D, Linnoila M, Paul SM.
    Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
    [Abstract] [Full Text] [Related]

  • 29. Impacts of age on plasma monoamine metabolite concentrations in a large cohort of healthy individuals.
    Soda E, Miura I, Hoshino H, Kanno-Nozaki K, Ota T, Oguchi H, Watanabe K, Yang Q, Mashiko H, Niwa S.
    Psychiatry Res; 2014 Dec 15; 220(1-2):639-45. PubMed ID: 25200191
    [Abstract] [Full Text] [Related]

  • 30. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.
    Thibaut F, Ribeyre JM, Dourmap N, Ménard JF, Dollfus S, Petit M.
    Biol Psychiatry; 1998 Jan 01; 43(1):24-30. PubMed ID: 9442341
    [Abstract] [Full Text] [Related]

  • 31. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL.
    Arch Gen Psychiatry; 1993 Aug 01; 50(8):599-605. PubMed ID: 7688208
    [Abstract] [Full Text] [Related]

  • 32. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
    Chang WH, Chen TY, Lin SK, Lung FW, Lin WL, Hu WH, Yeh EK.
    Biol Psychiatry; 1990 Mar 01; 27(5):510-8. PubMed ID: 2310806
    [Abstract] [Full Text] [Related]

  • 33. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
    Suzuki E, Kanba S, Nibuya M, Adachi S, Sekiya U, Shintani F, Kinoshita N, Yagi G, Asai M.
    Biol Psychiatry; 1994 Nov 15; 36(10):654-61. PubMed ID: 7880934
    [Abstract] [Full Text] [Related]

  • 34. Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
    Andreou D, Söderman E, Axelsson T, Sedvall GC, Terenius L, Agartz I, Jönsson EG.
    Psychiatry Res; 2015 Sep 30; 229(1-2):497-504. PubMed ID: 26142836
    [Abstract] [Full Text] [Related]

  • 35. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD, Geracioti TD, Altemus M, Kling MA.
    Biol Psychiatry; 2015 Sep 30; 33(8-9):636-41. PubMed ID: 7687151
    [Abstract] [Full Text] [Related]

  • 36. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics.
    Kim YK, Kim L, Lee MS.
    Schizophr Res; 2000 Sep 01; 44(3):165-75. PubMed ID: 10962218
    [Abstract] [Full Text] [Related]

  • 37. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K, Kanba S, Ohnishi K, Ashikari I, Yagi G, Asai M.
    Biol Psychiatry; 1997 May 15; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract] [Full Text] [Related]

  • 38. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL.
    Arch Gen Psychiatry; 1991 Oct 15; 48(10):910-3. PubMed ID: 1929760
    [Abstract] [Full Text] [Related]

  • 39. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium.
    Nakamura J, Uchimura N, Yamada S, Nakazawa Y.
    Int Clin Psychopharmacol; 1997 May 15; 12(3):147-52. PubMed ID: 9248871
    [Abstract] [Full Text] [Related]

  • 40. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment.
    Cai HL, Fang PF, Li HD, Zhang XH, Hu L, Yang W, Ye HS.
    Psychiatry Res; 2011 Jul 30; 188(2):197-202. PubMed ID: 21146875
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.